It's a surprise no one had expected. German drugmaker Merck is buying Swiss biotech firm Serono, creating a new force in European pharmaceuticals. Europe's mid-sized drugmakers, like Merck and Serono, have found themselves at a pinch-point in a global pharmaceutical industry facing tougher markets and rising research costsMerlin Koene, Reuter.